Skip to Main Content

Efficacy and Safety of OPN-375 186 ug Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps

Conditions

Children's Health | Diseases of the Respiratory Systems

Phase III

What is the purpose of this trial?

To evaluate the efficacy of intranasal administration of OPN-375 186 μg twice a day (BID) versus placebo in adolescents with bilateral nasal polyposis and nasal congestion

  • Trial with
    Optinose
  • Start Date
    04/28/2019
  • End Date
    12/30/2018

For more information about this study, contact:

Jeanine May

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/30/2019
  • Study HIC
    #2000023985